We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDN icon
526
Radian Group
RDN
$5.21B
$752K 0.01%
39,441
+4,041
+11% +$78.7K
DGX icon
527
Quest Diagnostics
DGX
$25.5B
$751K 0.01%
4,803
-273
-5% -$39.2K
ROKU icon
528
Roku
ROKU
$21.3B
$745K 0.01%
18,305
-120
-0.7% -$6.27K
STEP icon
529
StepStone Group
STEP
$3.63B
$743K 0.01%
29,500
-2,200
-7% -$61.5K
IMGN
530
DELISTED
Immunogen Inc
IMGN
$742K 0.01%
149,640
+29,172
+24% +$158K
CVS icon
531
CVS Health
CVS
$137B
$741K 0.01%
7,948
-705
-8% -$68K
IVZ icon
532
Invesco
IVZ
$13.2B
$738K 0.01%
41,007
+4,207
+11% +$72K
ACRS icon
533
Aclaris Therapeutics
ACRS
$732M
$712K 0.01%
+45,205
New +$727K
BLU
534
DELISTED
BELLUS Health Inc.
BLU
$698K 0.01%
84,953
+16,578
+24% +$155K
FULT icon
535
Fulton Financial
FULT
$4.69B
$697K 0.01%
41,442
-9,059
-18% -$159K
PETS icon
536
PetMed Express
PETS
$41.9M
$693K 0.01%
39,176
-8,566
-18% -$170K
BKNG icon
537
Booking.com
BKNG
$145B
$685K 0.01%
8,500
-2,375
-22% -$180K
ELV icon
538
Elevance Health
ELV
$82.2B
$679K 0.01%
1,323
-73
-5% -$37.1K
CRNX icon
539
Crinetics Pharmaceuticals
CRNX
$8.88B
$668K 0.01%
36,477
+7,151
+24% +$126K
RGNX icon
540
Regenxbio
RGNX
$631M
$666K 0.01%
29,345
+5,713
+24% +$129K
OPK icon
541
Opko Health
OPK
$929M
$656K 0.01%
524,592
+103,188
+24% +$163K
ENTA icon
542
Enanta Pharmaceuticals
ENTA
$376M
$655K 0.01%
14,079
+2,794
+25% +$127K
MRO
543
DELISTED
Marathon Oil Corporation
MRO
$654K 0.01%
24,162
-1,966
-8% -$57K
RC
544
Ready Capital
RC
$267M
$653K 0.01%
58,610
-12,807
-18% -$154K
DE icon
545
Deere & Co
DE
$167B
$645K 0.01%
1,505
+104
+7% +$42.3K
PLRX icon
546
Pliant Therapeutics
PLRX
$67.5M
$639K 0.01%
+33,073
New +$691K
NICE icon
547
Nice
NICE
$5.55B
$632K 0.01%
3,287
-798
-20% -$154K
NLY icon
548
Annaly Capital Management
NLY
$17B
$629K 0.01%
29,828
-6,518
-18% -$128K
EC icon
549
Ecopetrol
EC
$32.4B
$628K 0.01%
+60,000
New +$585K
REYN icon
550
Reynolds Consumer Products
REYN
$5.42B
$627K 0.01%
20,902
+2,172
+12% +$65.2K

Similar funds

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.